{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:35:33Z","timestamp":1787960133021,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jacep.2024.11.018","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T14:07:36Z","timestamp":1738764456000},"page":"792-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and Clinical Management of Supraventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-4400","authenticated-orcid":false,"given":"Brett C.","family":"Austin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-3497","authenticated-orcid":false,"given":"Gurukripa N.","family":"Kowlgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Almeida Lopes","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-0971","authenticated-orcid":false,"given":"Konstantinos C.","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.11.018_bib1","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachcyardia in children: a 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.018_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.018_bib3","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCEP.111.962027","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume":"5","author":"Leenhardt","year":"2012","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib5","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.11.018_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/hrt.37.3.339","article-title":"Bidirectional tachycardia in a child. A study using His bundle electrography","volume":"37","author":"Reid","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacep.2024.11.018_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/apha.12038","article-title":"Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia - is there a mechanistic link between sarcoplasmic reticulum Ca2+ leak and re-entry?","volume":"207","author":"Heijman","year":"2013","journal-title":"Acta Physiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib9","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1253\/circj.71.1606","article-title":"Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"71","author":"Sumitomo","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2024.11.018_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2020.08.029","article-title":"Comparison of frequency of atrial fibrillation in blacks versus whites and the utilization of race in a novel risk score","volume":"135","author":"Kowlgi","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/apha.12006","article-title":"Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts","volume":"207","author":"King","year":"2013","journal-title":"Acta Physiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib12","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.0000162461.67140.4C","article-title":"Defective cardiac ryanodine receptor regulation during atrial fibrillation","volume":"111","author":"Vest","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.018_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1540-8167.2008.01211.x","article-title":"Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation","volume":"19","author":"Pizzale","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.hrthm.2024.04.006","article-title":"An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"21","author":"Laba","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/europace\/eur277","article-title":"Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments","volume":"14","author":"Van Der Werf","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2024.11.018_bib16","article-title":"A\u00a0novel mutation in the ryr2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by \u03b2-blocker therapy","volume":"27","author":"Kazemian","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib17","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"Van Der Werf","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00380-009-1214-6","article-title":"Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia","volume":"25","author":"Sumitomo","year":"2010","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacep.2024.11.018_bib19","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.hrthm.2016.06.008","article-title":"Atrial fibrillation in inherited cardiac channelopathies: from mechanisms to management","volume":"13","author":"Enriquez","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.018_bib21","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.11.018_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12170-020-00645-5","article-title":"Predictors of outcomes in patients with atrial fibrillation: what can be used now and what hope is in the future","volume":"14","author":"Mehra","year":"2020","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.jacep.2024.11.018_bib23","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0735-1097(99)00438-6","article-title":"Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing","volume":"34","author":"Fisher","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.hrthm.2007.06.023","article-title":"Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents","volume":"4","author":"Wongcharoen","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.107.711606","article-title":"Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features","volume":"116","author":"Bhuiyan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.018_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.hrthm.2006.12.048","article-title":"Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Napolitano","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCEP.110.961243","article-title":"Minimizing inappropriate or \u201cunnecessary\u201d implantable cardioverter-defibrillator shocks: appropriate programming","volume":"4","author":"Koneru","year":"2011","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCEP.110.957670","article-title":"Posttraumatic stress and the implantable cardioverter-defibrillator patient what the electrophysiologist needs to know","volume":"4","author":"Sears","year":"2011","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib30","first-page":"1175","article-title":"Syncope and atrial fibrillation: Which is the chicken and which is the egg?","volume":"8","author":"Hussain","year":"2015","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacep.2024.11.018_bib31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0735-1097(93)90426-2","article-title":"Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation","volume":"22","author":"Brignole","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.11.018_bib32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.hrthm.2009.06.033","article-title":"Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca2+ regulation","volume":"6","author":"Cerrone","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.11.018_bib33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2024.11.018_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.11.018_bib35","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/STROKEAHA.110.591958","article-title":"Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm","volume":"41","author":"Stahrenberg","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jacep.2024.11.018_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jacep.2024.11.018_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/cvr\/cvt012","article-title":"Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current","volume":"98","author":"Sikkel","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2024.11.018_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jccase.2018.09.004","article-title":"Radiofrequency catheter ablation for drug-refractory atrial tachyarrhythmias in a patient with catecholaminergic polymorphic ventricular tachycardia: a case report","volume":"19","author":"Kawada","year":"2019","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jacep.2024.11.018_bib39","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24010259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24010259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:46:37Z","timestamp":1775022397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24010259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2405500X24010259"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.11.018","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Clinical Management of Supraventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}